prednisolone has been researched along with Craniofacial Abnormalities in 1 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Craniofacial Abnormalities: Congenital structural deformities, malformations, or other abnormalities of the cranium and facial bones.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanigawa, T | 1 |
| Tanaka, H | 1 |
| Sato, T | 1 |
| Banno, S | 1 |
| Kishimoto, M | 1 |
| Brodie, H | 1 |
| Ueda, H | 1 |
1 other study available for prednisolone and Craniofacial Abnormalities
| Article | Year |
|---|---|
Craniometaphyseal dysplasia unnoticed until 19 years of age: First diagnosed from facial nerve paralysis.
Topics: Anti-Inflammatory Agents; Bone Diseases, Developmental; Craniofacial Abnormalities; Delayed Diagnosi | 2011 |